Lupin receives tentative approval from USFDA for Obeticholic Acid Tablets
Obeticholic Acid Tablets (RLD Ocaliva) had estimated annual sales of US $255 million in the US (IQVIA MAT December 2022).
Obeticholic Acid Tablets (RLD Ocaliva) had estimated annual sales of US $255 million in the US (IQVIA MAT December 2022).
hubergroup’s two newly added medical vans are dedicated to dental and eye care
PM emphasises the need to enhance lab surveillance & testing of all Severe Acute Respiratory Illness (SARI) cases & ramp up genome sequencing
PM to launch TB-Mukt Panchayat initiative; official pan-India rollout of a shorter TB Preventive Treatment and Family-centric care model for TB
FedEx will be displaying a wide-range of effective healthcare packaging and specialized tracking technology
Integration of modern and traditional medicine to facilitate the illness to wellness journey
The data from this study show that MM-II has the potential to provide durable pain relief for our patients
The Congress gathers the whole value chain of the pharmaceutical industry on June, 12-13, 2023 in Switzerland
Tofacitinib Tablets, 5 mg and 10 mg had annual sales of US $900 million in the United States (IQVIA MAT December 2022)
The audit is a pre-approval inspection for three products filed from the facility
Subscribe To Our Newsletter & Stay Updated